Different experimental approaches in modelling cataractogenesis

Interdisciplinary Toxicology

Volumn 3, Issue 1, 2010, Pages 3-14

  Kyselova, Zuzana ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

crystallins; eye lens; nuclear cataract; rats; sodium selenite

Indexed keywords

2 OXOGLUTARIC ACID; CAFFEIC ACID PHENETHYL ESTER; CALPASTATIN; DREVOGENIN D; ELLAGIC ACID; GARLIC EXTRACT; GREEN TEA EXTRACT; LEVACECARNINE; LYCOPENE; MELATONIN; OCIMUM SANCTUM EXTRACT; PLANT EXTRACT; PLEUROTUS OSTREATUS EXTRACT; POLYMER; RESVERATROL; SELENIUM; SJA 6017; SODIUM CHLORIDE; SODIUM SELENITE; UNCLASSIFIED DRUG; VITEX NEGUNDO EXTRACT;

ANATOMY; BLINDNESS; CATARACT; CATARACTOGENESIS; CULTURE MEDIUM; EYE DEVELOPMENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHYSIOLOGY; PLEUROTUS OSTREATUS; PUBLIC HEALTH PROBLEM; REVIEW; SCREENING; SOLUTION AND SOLUBILITY; TEA; TOXICOLOGY;

RATTUS;

EID: 77956252318     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-010-0005-3     Document Type: Review

References (181)

1. Anderson RS, Shearer TR and Claycomb CK. (1986). Selenite-induced epithelial damage and cortical cataract. Curr Eye Res 5: 53-61.
2. Anderson RS, Trune DR and Shearer TR. (1988). Histologic changes in selenite cortical cataract. Invest Ophthalmol Vis Sci 29: 1418-1427.
3. Augusteyn RC. (2007). Growth of the human eye lens. Mol Vis 13: 252-257.
4. Aydin B, Yagci R, Yilmaz FM, Erdurmus M, Karada? R, Keskin U, Durmus M and Yigitoglu R. (2009). Prevention of selenite-induced cataractogenesis by N-acet-ylcysteine in rats. Curr Eye Res 34: 196-201.
5. Babizhayev MA, Guiotto A, and Kasus-Jacobi A. (2009). N-Acetylcarnosine and histidyl-hydrazide are potent agents for multitargeted ophthalmic therapy of senile cataracts and diabetic ocular complications. J Drug Target 17: 36-63.
6. Bassnett S. (2002). Lens organelle degradation. Exp Eye Res 74: 1-6.
7. Bassnett S. (2009). On the mechanism of organelle degradation in the vertebrate lens. Exp Eye Res 88: 13 3-139.
8. Bera S, Thampi P, Cho WJ and Abraham EC. (2002). A positive charge preservation at position 116 of αA-crystallin is critical for its structural and functional integrity. Biochemistry 41: 124 21-12426.
9. Biju PG, Rooban BN, Lija Y, Devi VG, Sahasranamam V and Abraham A (2007b) Drevogenin D prevents selenite-induced oxidative stress and calpain activation in cultured rat lens. Mol Vis 3: 1121-1129.
10. Biju PG, Devi VG, Lija Y and Abraham A (2007a) Protection against selenite cataract in rat lens by drevogenin D, a triterpenoid aglycone from Dregea volubilis. J Med Food 10: 308-315.
11. Bloemendal H. (1981). The lens proteins, in Molecular and Cellular Biology of the Eye Lens (Bloemendal H ed) pp. 1-49, John Willey & Sons, New York.
12. Bloemendal H, de Jong W, Jaenicke R, Lubsen NH, Slingsby C and Tardieu A. (2004). Ageing and vision: structure, stability and function of lens crystallins. Prog Biophys Mol Biol 86: 407-485.
13. Bosch AM. (2006). Classical galac tosaemia revisited. J Inherit Metal b Dis 29: 516-525.
14. Cao S, Durrani FA and Rustum YM. (2004). Selective modulation of the therapeutic ef cacy of anti-cancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10: 2561-2569.
15. Cenedella RJ. (1987). Direct chemical measurement of DNA synthesis and net rates of differentiation of rat lens epithelial cells in vivo: applied to the selenium cataract. Exp Eye Res 44: 677-690.
16. Cenedella RJ. (1998). Prenylation of proteins by the intact lens. Invest Ophthalmol Vis Sci 39: 1276-1280.
17. Cerami A and Crabbe J. (1986). Recent advances in ocular cataract research. TIPS Reviews 7: 271-274.
18. Chandra D, Ramana KV, Wang L, Christensen BN, Bhatnagar A and Srivastava SK. (2002). Inhibition of f ber cell globulization and hyperglycemia-induced lens opacif cation by aminopeptidase inhibitor bestatin. Invest Ophthalmol Vis Sci 43: 2285-2292.
19. Chandrasekher G and Cenedella RJ. (1993). Calcium activated proteolysis and protein modif cation in the U18666A cataract. Exp Eye Res 57: 737-745.
20. Cheng HM. (2002). Water dif usion in the rabbit lens in vivo. Dev Ophthalmol 35: 169-175.
21. Chikamoto N, Chikama T, Yamada N, Nishida T, Ishimitsu T and Kamiya A. (2009). Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superf cial punctate keratopathy in diabetic patients. Jpn J Ophthalmol 53: 464-469.
22. Churchill GC and Louis CF. (1999). Imaging of intracellular calcium stores in single permeabilized lens cells. Am J Physiol 276: C426-C434.
23. Combs GFJr, Midthune DN, Patterson KY, CanWeld WK, Hill AD, Levander OA, Taylor PR, Moler JE and Patterson BH. (2009). Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 89: 1808-1814.
24. David LL, Azuma M and Shearer TR. (1994). Cataract and the acceleration of cal-pain-induced β-crystallin insolubilization occurring during normal maturation of rat lens. Invest Ophthalmol Vis Sci 35: 785-793.
25. David LL, Shearer TR and Shih M. (1993). Sequence analysis of lens β-crystallins suggests involvement of calpain in cataract formation. J Biol Chem 268: 1937-1940.
26. de Jong WW, Caspers GJ and Leunissen JA. (1998). Genealogy of the α-crystallin-small heat-shock protein superfamily. Int J Biol Macromol 22: 151-162.
27. Descamps FJ, Martens E, Proost P, Starckx S, van den Steen PE, van Damme J and Opdenakker G. (2005). Gelatinase B/matrix metalloproteinase-9 provokes cataract by cleaving lens βB1-crystallin. FASE B J 19: 29-35.
28. Devamanoharan PS and Varma SD. (1995). Inhibition of polyol formation in rat lens by verapamil. J Ocul Pharmacol Ther 11: 527-531.
29. Dickerson JE, Lou MF and Gracy RW. (1995). The culture of rat lenses in high sugar media: Effect on mixed disulfide levels. Curr Eye Res 14: 109-118.
30. Dickerson JEJr, Dotzel E and Clark AF. (1997). Steroid-induced cataract: new perspective from in vitro and lens culture studies. Exp Eye Res 65: 507-516.
31. Dillon J, Roy D, Spector A, Walker ML, Hibbard LB and Borkman R F. (1989). UV laser photodamage to whole lenses. Exp Eye Res 49: 959-966.
32. Doganay S, Borazan M, Iraz M and Cigremis Y. (2006). The Effect of resveratrol in experimental cataract model formed by sodium selenite. Curr Eye Res 31: 147-153.
33. Doganay S, Turkoz Y, Evereklioglu C, Er H, Bozaran M and Ozerol E. (2002). Use of caf eic acid phenethyl ester to prevent sodium selenite-induced cataract in rat eyes. J Cataract Refr Surg 28: 1457-1462.
34. Duncan G, Webb SF, Dawson AP, Bootman MD and Elliott AJ. (1993). Calcium regulation in tissue-cultured human and bovine lens epithelial cells. Invest Oph-thalmol Vis Sci 34: 2835-2842.
35. Duncan G, Williams MR and Raich RA. (1994). Calcium, cell signaling and cataract. Prog Ret Eye Res 13: 623-652.
36. Elanchezhian R, Ramesh E, Sakthivel M, Isai M, Geraldine P, Rajamohan M, Jesu-dasan CN and Thomas PA. (2007). Acetyl-L-carnitine prevents selenite-induced cataractogenesis in an experimental animal model. Curr Eye Res 32: 961-971.
37. Elanchezhian R, Sakthivel M, Geraldine P and Thomas PA. (2010). Regulatory effect of acetyl-l-carnitine on expression of lenticular antioxidant and apoptotic genes in selenite-induced cataract. Chem Biol Interact in press.
38. El-Bayoumy K. (2001). The protective role of selenium on genetic damage and on cancer. Mutat Res 475: 12 3-13 9.
39. El-Shenawy SM and Hassan NS. (2008). Comparative evaluation of the protective Effect of selenium and garlic against liver and kidney damage induced by mercury chloride in the rats. Pharmacol Rep 60: 199-208.
40. Fan X, Zhang J, Theves M, Strauch C, Nemet I, Liu X, Qian J, Giblin FJ and Monnier VM. (2009). Mechanism of lysine oxidation in human lens crystallins during aging and in diabetes. J Biol Chem 284: 34618-34627.
41. Food and Nutrition Board-USA Institute of Medicine. (2000). Dietary References Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington: National Academy Press.
42. Fris M, Tessem MB, Sather O and Midelfart A. (2006). Biochemical changes in sele-nite cataract model measured by high-resolution MAS (1)H NMR spectroscopy. Acta Ophthalmol Scand 84: 684-692.
43. Fujii N, Takeuchi N, Fujii N, Tezuka T, Kuge K, Takata T, Kamei A and Saito T. (2004). Comparison of post-translational modif cations of αA-crystallin from normal and hereditary cataract rats. Amino Acids 26: 147-152.
44. Fukiage C, Azuma M, Nakamura Y, Tamada Y, Nakamura M and Shearer TR. (1997). SJA6017, a newly synthesized peptide aldehyde inhibitor of calpain: amelioration of cataract in cultured rat lenses. Biochim Biophys Acta 1361: 304-312.
45. Galvan A and Louis CF. (1988). Calcium regulation by lens plasma membrane vesicles. Arch Biochem Biophys 264: 472-481.
46. Gan L, Liu Q, Xu HB, Zhu YS and Yang XL. (2002). Effects of selenium overexpo-sure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biol Trace Elem Res 89: 165-175.
47. Garcia-Porrero JA, Collado JA and Ojeda JL. (1979). Cell death during detachment of the lens r udime nt from ec to derm in the chick embr yo. Anat Rec 193: 791-804.
48. Ghosh MP and Zigler JS. (2005). Lack of fiber cell induction stops normal growth of rat lenses in organ culture. Mol Vis 11: 901-908.
49. Gift BW, English RV, Nadelstein B, Weigt AK and Gilger BC. (2009). Comparison of capsular opacification and refractive status after placement of three different intraocular lens implants following phacoemulsification and aspiration of cataracts in dogs. Vet Ophthalmol 12: 13-21.
50. Girao H, Mota C and Pereira P. (1999). Cholesterol may act as an antioxidant in lens membranes. Curr Eye Res 18: 448-454.
51. Goldhaber SB. (2003). Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38: 232-242.
52. Graw J. (2003). The genetic and molecular basis of congenital eye defects. Nat Rev Genet 4: 877-888.
53. Groenen PJ, Grootjans JJ, Lubsen NH, Bloemendal H and de Jong WW. (1994). Lys-17 is the amine-donor substrate site for transglutaminase in βA3-crystallin. J Biol Chem 269: 831-833.
54. Gupta SK, Trivedi D, Srivastava S, Joshi S, Halder N and Varma SD. (2003). Lyco-pene attenuates oxidative stress-induced experimental cataract development: an in vitro and in vivo study. Nutrition 19: 794-799.
55. Gupta SK, Srivastava S, Trivedi D, Joshi S and Halder N. (2005). Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification. Curr Eye Res 30: 583-591.
56. Gupta SK, Halder N, Srivastava S, Trivedi D, Joshi S and Varma SD. (2002). Green tea (Camellia sinensis) protects against selenite-induced oxidative stress in experimental cataractogenesis. Ophthalmic Res 34: 258-263.
57. Hains P and Truscott RJ. (2010). Age-dependent deamidation of life-long proteins in the human lens. Invest Ophthalmol Vis Sci in press.
58. Hales AM, Chamberlain CG and McAvoy JW. (1995). Cataract induction in lenses cultured with transforming-growth-factor-β. Invest Ophthalmol Vis Sci 36: 170 9-17 13.
59. Hamakubo T, Kannagi R, Murachi T and Matus A. (1986). Distribution of calpains I and II in rat brain. J Neurosci 6: 3 103-3111.
60. Hammond CJ, Duncan DD, Snieder H, de Lange M, West SK, Spector TD and Gilbert CE. (2001). The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci 42: 601-605.
61. Harding JJ. (1991). Post-translational modif cation of lens proteins in cataract. Lens Eye Toxic Res 8: 245-250.
62. Hetts SW. (1998). To die or not to die: An overview of apoptosis and its role in disease. JAMA 279: 300-307.
63. Horwitz J. (2003). Alpha-crystallin. Exp Eye Res 76: 145-153.
64. Huang LL, Hess JL and Bunce GE. (1990). DNA damage, repair and replication in selenite-induced cataract in rat lens. Curr Eye Res 9: 1041-1050.
65. Huang LL, Zhang C-Y, Hess JL and Bunce GE. (1992). Biochemical changes and cataract formation in lenses from rats receiving multiple, low doses of sodium selenite. Exp Eye Res 55: 671-678.
66. Huang FY, Ho Y, Shaw TS and Chuang SA. (2000). Functional and structural studies of α-crystallin from galactosemic rat lenses. Biochem Biophys Res Commun 273: 197-202.
67. Huang WQ, Zhang JP and Fu JSC. (1990). Differential Effects of galactose-induced cataractogenesis on the soluble crystallins of rat lens. Exp Eye Res 51: 79-85.
68. Isai M, Elanchezhian R, Sakthivel M, Chinnakkaruppan A, Rajamohan M, Jesu-dasan CN, Thomas PA and Geraldine P (2009b) Anti-cataractogenic Effect of an extract of the oyster mushroom, Pleurotus ostreatus, in an experimental animal model. Curr Eye Res 34: 264-273.
69. Isai M, Sakthivel M, Ramesh E, Thomas PA and Geraldine P (2009a) Prevention of selenite-induced cataractogenesis by rutin in Wistar rats. Mol Vis 15: 2570-2577.
70. Ito H, Iida K, Kamei K, Iwamoto I, Inaguma Y and Kato K. (1999). αB-crystallin in the rat lens is phosphorylated at an early post-natal age. FEBS Lett 446: 269-272.
71. Jacob R F, Cenedella RJ and Mason RP. (1999). Direct evidence for immiscible cholesterol domains in human ocular lens f ber cell plasma membranes. J Biol Chem 274: 31613-31618.
72. Jacques PF and Chylack LTJr. (1991). Epidemiologic evidence of a role for the an-tioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 53: 352S-355S.
73. Jacques PF and Taylor A. (1991). Micronutrients and age-related cataracts, in Mi-cronutrients in health and in disease prevention (Bendich A and Butterworth CE eds) pp. 359-379, Dekker, New York.
74. Jaf e NS and Horwitz J. (1991). Lens and Cataract, in Text Book of Ophthalmology 3 (Podos SM and Yanof M eds) Gower Med. Publishing, New York.
75. Javadzadeh A, Ghorbanihaghjo A, Arami S, Rashtchizadeh N, Mesgari M, Rafeey M and Omidi Y (2009a) Prevention of selenite-induced cataractogenesis in Wi-star albino rats by aqueous extract of garlic. J Ocul Pharmacol Ther 25: 395-400.
76. Javadzadeh A, Ghorbanihaghjo A, Bonyadi S, Rashidi MR, Mesgari M, Rashtchiza-deh N and Argani H (2009b) Preventive Effect of onion juice on selenite-in-duced experimental cataract. Indian J Ophthalmol 57: 18 5-189.
77. Jedziniak JA, Chylack LTJr, Cheng HM, Gillis MK, Kalustian AA and Tung WH. (1981). The sorbitol pathway in the human lens: aldose reductase and polyol dehy-drogenase. Invest Ophthalmol Vis Sci 20: 314-326.
78. Johnson GJ and Foster A. (2004). Prevalence, incidence and distribution of visual impairment, in The epidemiology of eye disease (Johnson GJ, Minassian DC, Weale RA and West SK eds), pp. 3-28, Arnold, London, UK.
79. Kador PF, Takahashi Y, Akagi Y, Blessing K, Randazzo J and Wyman M. (2007). Age-dependent retinal capillary pericyte degeneration in galactose-fed dogs. J Ocul Pharmacol Ther 23: 63-69.
80. Kanamoto T, Souchelnytskyi N and Kiuchi Y. (2009). Functional proteomics of failed filtering blebs. Mol Vis 15: 2762-2770.
81. Kinoshita JH and Wachtl C. (1958). A study of the C14-glucose metabolism of the rabbit lens. J Biol Chem 233: 5-7.
82. Kinoshita JH. (1974). Mechanisms initiating cataract formation. Proctor Lecture. Invest Ophthalmol 13: 713-724.
83. Kitahara J, Seko Y and Imura N. (1993). Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes. Arch Toxicol 67: 497-501.
84. Klemenz R, Fröhli E, Aoyama A, Hoffmann S, Simpson RJ, Moritz RL and Schäfer R. (1991). αB-crystallin accumulation is a specific response to Ha-ras and v-mos oncogene expression in mouse NIH 3T3 fibroblasts. Mol Cell Biol 11: 803-812.
85. 3) in Salmonella typhimurium. Mutat Res 201: 169-180.
86. Kuck JFRJr. (1970). Clinical constituents of the lens, metabolism of the lens, cataract formation, in Biochemistry of the eye (Graymore CN ed) pp. 183-371, Academic Press, New York.
87. Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ and Reddy GB (2005a) Elevated expression of αA-and αB-crystallins in streptozotocin- induced diabetic rat. Arch Biochem Biophys 444: 77-83.
88. Kumar PA, Reddy PY, Srinivas PN and Reddy GB. (2009). Delay of diabetic cataract in rats by the anti-glycating potential of cumin through modulation of α-crystallin chaperone activity. J Nutr Biochem 20: 553-562.
89. Kumar PA, Suryanarayana P, Reddy PY and Reddy GB (2005b) Modulation of α-crystallin chaperone activity in diabetic rat lens by curcumin. Mol Vis 11: 561-568.
90. Kupfer C. (1984). The conquest of cataract: A global challenge. Trans Ophthal Soc UK 104: 1-10.
91. Kuszak JR. (1990). Embryology and anatomy of the lens, in: Clinical Ophthalmology (Tasman W, Jaeger EA eds) pp 1-9, J.B. Lippincott, Philadelphia.
92. Kyselova Z, Gajdosik A, Gajdosikova A, Ulicna O, Mihalova D, Karasu C and Stefek M (2005b) Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis 11: 56-65.
93. Kyselova Z, Garcia SJ, Gajdosikova A, Gajdosik A and Stefek M (2005a) Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats. Physiol Res 54: 49-56.
94. Kyselova Z, Krizanova L, Soltes L and Stefek M (2005c) Electrophoretic analysis of oxidatively modified eye lens proteins in vitro: implications for diabetic cataract. J Chromatogr A 1084: 95-100.
95. Lampi KJ, Shih M, Ueda Y, Shearer TR and David LL. (2002). Lens proteomics: analysis of rat crystallin sequences and two-dimensional electrophoresis map. Invest Ophthalmol Vis Sci 43: 216-224.
96. Lang R, Lustig M, Francois F, Sellinger M and Plesken H. (1994). Apoptosis during macrophage-dependent ocular tissue remodeling. Development 120: 3395-3403.
97. Lapolla A, Fedele D, Seraglia R and Traldi P. (2006). The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update. Mass Spectrom Rev 25: 775-797.
98. Latker CH and Kuwabara T. (1981). Regression of the tunica vasculosa lentis in the postnatal rat. Invest Ophthalmol Vis Sci 21: 689-699.
99. Lee AY and Chung SS. (1998). Involvement of aldose reductase in naphthalene cataract. Invest Ophthalmol Vis Sci 39: 19 3-19 7.
100. Letavayova L, Vlckova V and Brozmanova J. (2006). Selenium: from cancer prevention to DNA damage. Toxicology 227: 1-14.
101. Li WC, Kuszak JR, Dunn K, Wang RR, Ma W, Wang GM, Spector A, Leib M, Cotliar AM, Weiss M, Espy J, Howard G, Farris RL, Auran J, Donn A, Hofeldt A, Mackay C, Merrian J, Mittl R and Smith TR (1995b) Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in human and animals. J Cell Biol 130: 169-181.
102. Li, WC, Kuszak JR, Wang GM, Wu ZQ and Spector A (1995a) Calcimycin-induced lens epithelial cell apoptosis contributes to cataract formation. Exp Eye Res 61: 91-98.
103. Lorenzi M. (2007). The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res Article ID 61038, 10 pages.
104. 2-induced cataract in rat lenses: distributions and Effect of aging. Curr Eye Res 14: 951-958.
105. Lovicu FJ and Robinson ML. (2004). Development of the Ocular Lens (Lovicu FJ and Robinson ML eds) Cambridge University Press, Cambridge, UK.
106. Lu J, Kaeck M, Jiang, C, Wilson AC and Thompson HJ. (1994). Selenite induction of DNA strand breaks and apoptosis in mouse leukemic L1210 cells. Biochem Pharmacol 47: 1531-1535.
107. Ma H, Hata I, Shih M, Fukiage C, Nakamura Y, Azuma M and Shearer TR. (1999). Lp82 is the dominant form of calpain in young mouse lens. Exp Eye Res 68: 447-456.
108. MacCoss MJ, McDonald WH, Saraf A, Sadygov R, Clark JM, Tasto JJ, Gould KL, Wolters D, Washburn M, Weiss A, Clark JI and Yates JRI. (2002). Shotgun identi-f cation of protein modif cations from protein complexes and lens tissue. Proc Nat Acad Sci USA 99: 7900-7905.
109. Manikandan R, Thiagarajana R, Beulaja S, Chindhud S, Mariammale K, Sudhan-diranc G and Arumugama M. (2009). Anti-cataractogenic Effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lens. Chem Biol Interact 181: 202-209.
110. Michael R, Vrensen GF, van Marle J, Gan L and Soderberg PG. (1998). Apoptosis in the rat lens after in vivo threshold dose ultraviolet irradiation. Invest Ophthal-mol Vis Sci 39: 2681-2687.
111. Minassian DC, Reidy A, Desai P, Farrow S, Vaf dis G and Minassian A. (2000). The def cit in cataract surgery in England and Wales and the escalating problem of visual impairment: epidemiological modeling of the population dynamics of cataract. Br J Ophthalmol 84: 4-8.
112. Mitton KP, Hess JL and Bunce GE. (1997). Free amino acids rEffect impact of sele-nite-dependent stress on primary metabolism in rat lens. Curr Eye Res 16: 997-10 05.
113. Mitton K P, Linklater HA, Dzialoszynski T, Sanford SE, Starkey K and Trevithick JR. (1999). Modelling cortical cataractogenesis 21: in diabetic rat lenses taurine supplementation partially reduces damage resulting from osmotic compensation leading to osmolyte loss and antioxidant depletion. Exp Eye Res 69: 279-289.
114. Nakajima T, Nakajima E, Fukiage C, Azuma M and Shearer TR. (2002). Differential gene expression in the lens epithelial cells from selenite injected rats. Exp Eye Res 74: 231-236.
115. Nakamura Y, Fukiage C, Azuma M and Shearer TR. (1999). Oxidation enhances calpain-induced turbidity in young rat lenses. Curr Eye Res 19: 33-40.
116. Nakamura Y, Fukiage C, Shih M, Ma H, David LL, Azuma M and Shearer TR. (2000). Contribution of calpain Lp82-induced proteolysis to experimental cataracto-genesis in mice. Investig Ophthalmol Vis Sci 41: 1460-1466.
117. Navarro-Alarcon M and Cabrera-Vique C. (2008). Selenium in food and the human body: a review. Sci Total Environ 400: 115-141.
118. Newairy AA, El-Sharaky AS, Badreldeen MM, Eweda SM and Sheweita SA. (2007). The hepatoprotective Effects of selenium against cadmium toxicity in rats. Toxicology 242: 23-30.
119. Niwa T. (2007). Protein glutathionylation and oxidative stress. J Chromatogr B An-alyt Technol Biomed Life Sci 855: 59-65.
120. Olofsson EM, Marklund SL and Behndig A. (2007). Glucose-induced cataract in CuZn-SO D null lenses: an effect of nitric oxide? Free Radic Biol Med 42: 1098-1105.
121. Ostadalova I, Babicky A and Obenberger J. (1978). Cataract induced by administration of a single dose of sodium selenite to suckling rats. Experientia 34: 222-223.
122. Ozaki Y, Mizuno A, Itoh K and Iriyama K. (1987). Inter-and intra-molecular disul-f de bond formation and related structural changes in the lens proteins. A Raman spectroscopic study in vivo of lens aging. J Biol Chem 262: 1554 5-15 551.
123. Padival S and Nagaraj RH. (2006). Pyridoxamine inhibits Maillard reactions in diabetic rat lenses. Ophthalmic Res 38: 294-302.
124. Paron I, D'Elia A, D'Ambrosio C, Scaloni A, D'Aurizio F, Prescott A, Damante G and Tell G. (2004). A proteomic approach to identify early molecular targets of oxi-dative stress in human epithelial lens cells. Biochem J 378: 929-937.
125. Ponce A, Sorensen C and Takemoto L. (2006). Role of short-range protein interactions in lens opacifications. Mol Vis 12: 879-884.
126. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ and Zack DJ. (1995). Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 36: 774-786.
127. Rao G, Santhoshkumar P and Sharma KK. (2008). Anti-chaperone βA3/A1(102-117) peptide interacting sites in human αB-crystallin. Mol Vis 14: 666-674.
128. Rayman MP. (2000). The importance of selenium to human health. Lancet 356: 233-241.
129. Rayman MP. (2005). Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 64: 527-542.
130. Reid ME, Stratton MS, Lillico AJ, Fakih M, Natarajan R, Clark LC and Marshall JR. (2004). A report of high-dose selenium supplementation: response and toxici-ties. J Trace Elem Med Biol 18: 69-74.
131. Robman L and Taylor H. (2005). External factors in the development of cataract. Eye (Lond) 19: 1074-1082.
132. Rooban BN, Lija Y, Biju G, Sasikala V, Sahasranamam V and Abraham A. (2009). Vitex negundo attenuates calpain activation and cataractogenesis in selenite models. Exp Eye Res 88: 575-582.
133. Sakthivel M, Elanchezhian R, Ramesh E, Isai M, Jesudasan CN, Thomas PA and Geraldine P. (2008). Prevention of selenite-induced cataractogenesis in Wistar rats by the polyphenol, ellagic acid. Exp Eye Res 86: 251-259.
134. Satake M, Dmochowska B, Nishikawa Y, Madaj J, Xue J, Guo Z, Reddy DV, Rinaldi PL and Monnier VM. (2003). Vitamin C metabolomic mapping in the lens with 6-deoxy-6-f uoro-ascorbic acid and high-resolution 19F-NMR spectroscopy. Invest Ophthalmol Vis Sci 44: 2047-2058.
135. Saxena P, Saxena AK and Monnier VM. (1996). High galactose levels in vitro and in vivo impair ascorbate regeneration and increase ascorbate-mediated glyca-tion in cultured rat lens. Exp Eye Res 63: 535-545.
136. Schook P. (1980). Morphogenetic movements during the early development of the chick eye: An ultrastructual and spatial study. Acta Morphol Neerl Scand 18: 19 5-2 01.
137. Shamsi FA, Sharkey E, Creighton D and Nagaraj RH. (2000). Maillard reactions in lens proteins: methylglyoxal-mediated modif cations in the rat lens. Exp Eye Res 70: 369-380.
138. Shearer TR, Anderson RS and Britton JL. (1983). Inf uence of selenite and fourteen trace elements on cataractogenesis in the rat. Invest Ophthalmol Vis Sci 24: 417-423.
139. Shearer TR, David LL, Anderson RS and Azuma M. (1992). Review of selenite cataract. Curr Eye Res 11: 357-369.
140. Shearer TR and Hadjimarkos DM. (1973). Comparative distribution of 75 Se in the hard and soft tissues of mother rats and their pups. J Nutr 103: 553-559.
141. Shearer TR, Ma H, Fukiage C and Azuma M. (1997). Selenite nuclear cataract: review of the model. Mol Vis 3: 8-15.
142. Shih M, Ma H, Nakajima E, David LL, Azuma M and Shearer TR. (2006). Biochemical properties of lens-specific calpain Lp85. Exp Eye Res 82: 146-152.
143. Son HY, Kim H and H Kwon Y. (2007). Taurine prevents oxidative damage of high glucose-induced cataractogenesis in isolated rat lenses. J Nutr Sci Vitaminol 53: 324-330.
144. Spallholz JE. (1994). On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 17: 45-64.
145. Spallholz JE. (1997). Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci 10: 260-270.
146. Spector A. (2000). Review: oxidative stress and diseases. J Ocul Pharmacol Ther 16: 193-201.
147. Spector A. (1991). The lens and oxidative stress, in Oxidative Stress, Oxidants and Antioxidants (Sies H, ed) pp. 529-558, Academic Press, London.
148. Spector A, Kuszak JR, Ma W, Wang RR, Ho Y and Yang Y. (1998). The Effect of photochemical stress upon the lenses of normal and glutathione peroxidase-1 knockout mice. Exp Eye Res 67: 457-471.
149. Stadtman TC. (1991). Biosynthesis and function of selenocysteine- containing enzymes. J Biol Chem 266: 16257-1626 0.
150. Stitt AW. (2001). Advanced glycation: an important pathological event in diabetic and age-related ocular disease. Br J Ophthalmol 85: 746-753.
151. Surolia I, Sinha S, Sarkar D P, Reddy PY, Reddy GB and Surolia A. (2008). Concurrence of Danish dementia and cataract: insights from the interactions of dementia associated peptides with eye lens α-crystallin. PLoS One 3: e2927.
152. Swamy-Mruthinti S, Green K and Abraham EC. (1996). Inhibition of cataracts in moderately diabetic rats by aminoguanidine. Exp Eye Res 62: 505-510.
153. Takemoto L and Sorensen CM. (2008). Protein-protein interactions and lens transparency. Exp Eye Res 87: 496-501.
154. Tamada Y, Fukiage C, Nakamura Y, Azuma M, Kim YH and Shearer TR. (2000). Evidence for apoptosis in the selenite rat model of cataract. Biochem Biophys Res Commun 275: 300-306.
155. Tamada Y, Fukiage C, Mizutani K, Yamaguchi M, Nakamura Y, Azuma M and Shearer TR. (2001). Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats. Curr Eye Res 22: 280-285.
156. Taylor A and Nowell T. (1997). Oxidative stress and antioxidant function in relation to risk for cataract. Adv Pharmacol 38: 515-536.
157. Theodoropoulou S, Theodossiadis P, Samoli E, Vergados I, Lagiou P and Tzonou A. (2010). The epidemiology of cataract: A study in Greece. Acta Ophthalmol in press.
158. Thorpe SR and Baynes JW. (1996). Role of the Maillard reaction in diabetes mel-litus and diseases of aging. Drugs Aging 9: 69-77.
159. Ueda Y, Fukiage C, Shih M, Shearer TR and David LL. (2002). Mass measurements of C-terminally truncated α-crystallins from two-dimensional gels identify Lp82 as a major endopeptidase in rat lens. Mol Cell Proteomics 1: 357-365.
160. Valdiglesias V, Pásaro E, Méndez J and Laffon B. (2009). In vitro evaluation of selenium genotoxic, cytotoxic, and protective Effects: a review. Arch Toxicol in press.
161. VanMarle J and Vrensen GF. (2000). Cholesterol content of focal opacities and multilamellar bodies in the human lens: f lipin cytochemistry and freeze fracture. Ophthalmic Res 32: 285-291.
162. Varma SD and Hedge KR. (2004). Effect of α-ketoglutarate against selenite cataract formation. Exp Eye Res 79: 913-918.
163. Varma SD. (1991). Scientif c basis for medical therapy of cataracts by antioxidants. Am J Clin Nutr 53: 335-345.
164. Vaux DL and Strasser A. (1996). The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239-2244.
165. 2+ transport. Curr Eye Res 12: 213-218.
166. Wang KK, Nath W, Raser KJ and Hajimohammadreza I. (1996). Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. Arch Biochem Biophys 331: 208-214.
167. Waters DJ, Shen S, Glickman LT, Cooley DM, Bostwick DG, Qian J, Combs GFJr and Morris JS. (2005). Prostate cancer risk and DNA damage: translational sig-nif cance of selenium supplementation in a canine model. Carcinogenesis 26: 1256-1262.
168. West SK. (2000). Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol Rev 22: 64-70.
169. Whanger PD. (2004). Selenium and its relationship to cancer: an update. Br J Nutr 91: 11-28.
170. Wilmarth PA, Tanner S, Dasari S, Nagalla SR, Riviere MA, Bafna V, Pevzner PA and David LL. (2006). Age-related changes in human crystallins determined from comparative analysis of post-translational modif cations in young and aged lens: does deamidation contribute to crystallin insolubility? J Proteome Res 5: 2554-2566.
171. Worgul BV, Medvedovsky C, Huang Y, Marino SA, Randers-Pehrson G and Brenner DJ. (1996). Quantitative assessment of the cataractogenic potential of very low doses of neutrons. Radiat Res 145: 343-349.
172. Wycherly BJ, Moak MA and Christensen MJ. (2004). High dietary intake of sodium selenite induces oxidative DNA damage in rat liver. Nutr Cancer 48: 78-83.
173. Xu GT, Zigler JSJr and Lou M F. (1992). Establishment of a naphthalene cataract model in vitro. Exp Eye Res 54: 73-81.
174. Yáci R, Aydin B, Erdurmu M, Karada R, Gürel A, Durmu M and Yiitolu R. (2006). Use of melatonin to prevent selenite-induced cataract formation in rat eyes. Curr Eye Res 31: 845-850.
175. Yan L and Spallholz JE. (1993). Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells. Bio-chem Pharmacol 45: 429-437.
176. Zhang J and Wang S. (2009). Topical use of Coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract Effect. Int J Pharm 372: 66-75.
177. Zhang C, Liu P, Wang N, Li Y and Wang L. (2007). Comparison of two tandem mass spectrometry-based methods for analyzing the proteome of healthy human lens fibers. Mol Vis 13: 1873-1877.
178. Zhang Z, Smith DL and Smith JB. (2001). Multiple separations facilitate identif cation of protein variants by mass spectrometry. Proteomics 1: 1001-1009.
179. Zhou YJ, Zhang S P, Liu CW and Cai YQ. (2009). The protection of selenium on ROS mediated-apoptosis by mitochondria dysfunction in cadmium-induced LLCPK1 cells. Toxicol In Vitro 23: 288-294.
180. Zhou N, Xiao H, Li TK, Nur-E-Kamal A and Liu LF. (2003). DNA damage-mediated apoptosis induced by selenium compounds. J Biol Chem 278: 29532-29537.
181. Zigler JSJr, Qin C, Kamiya T, Krishna MC, Cheng Q, Tumminia S and Russell P. (2003). Tempol-H inhibits opacif cation of lenses in organ culture. Free Radic Biol Med 35: 1194-1202.